人血清血卟啉荧光光谱的双正交样条小波识别

Identification of Protoporphyrin IX Fluorescence Spectrum in Human Blood Serum by Biorthogonal Spline Wavelet

人血清中血卟啉含量很低,其荧光光谱强度很弱,往往呈肩峰形态,难以识别其位置和荧光强度。双正交样条小波可实现对其弱信号的分辨。在血清背景荧光光谱上叠加血卟啉荧光信号,并改变其荧光强度,得到一系列强度改变的血清血卟啉荧光光谱。用双正交样条小波bior5.5对获取的荧光光谱通过7次小波分解,将背景与卟啉荧光信号分离,得到了离散逼近信号（a1～a7）和离散细节信号（d1～d7）。结果表明,信号频率随着分解次数的增加逐步降低。当分解到第7次时,出现了血卟啉荧光特征峰。信号峰的位置随着信号强度的下降蓝移约2.5nm,而通过小波滤波器提取的信号峰的位置不变。随着信号的强度降低,信号峰的位置逐渐消失,因而其荧光强度与荧光峰的位置无法确定,而通过小波滤波器提取的信号则不受影响,且灵敏度高,从而实现了用双正交样条小波对人血清血卟啉荧光光谱的识别。由于小波变换是线性变换,离散细节信号保持信号原有的线性关系,可以用来对血清中所含血卟啉的准确成份和定量信息,从而进行定性和定量分析,为血清荧光光谱用于肿瘤的早期诊断提供了一种方法。

For the low content and weak fluorescence intensity, usually presenting shoulder peaks, it is often hard to locate protoporphyrin IX and identify its fluorescence intensity in human blood serum. Biorthogonal spline wavelet may work for the identification of its weak signal. Superimposing protoporphyrin IX fluorescence signal on the background of blood serum spectrum, a series of varied fluorescence spectra of them can be obtained. The protoporphyrin IX fluorescence signal from blood serum background is separated and the fluorescence spectrum can be divided into corresponding discrete approximate signals （a1-a7 ） and discrete details signals （d1 -d7 ） by biorthogonal spline wavelet bior 5.5 seven levels decomposition. The signal frequency shows a gradual decrease with increasing decomposition. Protoporphyrin IX fluorescence peak emerges when it comes to the 7th decomposition. The signal peak shifts about 2.5 mm downwards as the signal intensity decreases, whereas the signal peak from wavelet filter remains where it was. As the synchronization disappears between signal intensity and signal peak, usually it is hard to assure the fluorescence intensity and peak location. However, signal from wavelet filter may ignore the affect and identify the protoporphyrin IX in human blood serum with the help of biorthogonal spline wavelet. As the linear alternation of wavelet and discrete details signals maintain their inborn linear relations, the authors can carry out the qualitative and quantitative analysis for the precise content and quantity of protoporphyrin IX in blood serum, which provides a feasible method for the application of blood serum fluorescence spectrum to tumor early diagnosis.